Skip to content

Acute Effects of Different Exercises on Blood Pressure in Hypertensive Subjects

Hemodynamic, Autonomic and Inflammatory Answers to Different Types of Exercises in Resistant Hypertensive Patients: an Metabolomic Approach

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02987452
Enrollment
30
Registered
2016-12-09
Start date
2017-01-31
Completion date
2018-03-31
Last updated
2016-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

exercise, resistant hypertension, blood pressure

Brief summary

Lifestyle changes might reduce cardiovascular risk due to the decrease in blood pressure (BP). However, whether combining aerobic and resistance exercises affect BP and hemodynamic parameters, as well as arterial stiffness and inflammation markers in resistant hypertensive (RHTN) patients, have not been investigated yet.

Detailed description

Objective: The investigators aim to evaluate the acute effects of aerobic, resistance and combined (aerobic+ resistance) exercise on the BP, hemodynamic and inflammatory parameters, as well as arterial stiffness in RHTN patients compared to mild to moderate hypertensive (HTN) and normotensive (NT) subjects. Design and Methods: This interventional, randomized, single-blind, crossover study will be conducted in 30 patients (RHTN=10, HTN=10, and NT=10) regularly followed in the Outpatient Resistant Hypertension Clinic at UNICAMP- Brazil. All the subjects will be submitted to a previous adaptation of physical activity, especially to determine the load to be implemented in each patient. Then, the modalities of physical exercises (aerobic, resistance and combined) will be randomly performed in three isolated sessions, which will consist of: a) Aerobic exercise (EA): activity on a treadmill lasting 45 minutes with intensity of 50-60% of maximum heart rate (HR) obtained from ergometer test; b) resistance exercise (RE): 4 series of 12 repetitions of resistance exercises at moderate intensity (until moderate fatigue), for 45 minutes; c) combined exercise (CE): EA (25 minutes) + ER (20 minutes), with an interval of 2 minutes between sessions totalizing 45 minutes. Body composition (plethysmography) and cardiorespiratory functional capacity (ergometry) will be determined before the physical training. In addition, the investigators will assess BP recording (by Finometer, office and ambulatory BP), arterial stiffness (by pulse wave velocity, Sphygmocor CPV system), plasma biomarkers (TNF-α, interleukins -1, -6, -10, and -17 by ELISA) in pre and post periods of each physical exercise. Results: Since the physical exercise in its different modalities provides chronic effects on BP in HTN patients, the investigators hypothesized that the isolated (aerobic and resistance) and combined exercise can acutely promote changes in BP levels in RHTN patients when compared to the participants counterparts. Secondarily, some biological mechanisms related to BP control (vascular function and cytokines production) may also be involved in these possible alterations. Conclusion: The investigators expect to define whether a physical exercise program applied to RHTN patients has medical relevance in a realistic clinical setting. These findings may guide the prescription of physical activity as an additional therapeutic approach, in order to decrease the cardiovascular risk associated to these subjects.

Interventions

OTHERaerobic exercise

Aerobic exercise (EA): activity on a treadmill lasting 45 minutes with intensity of 50-60% of maximum heart rate (HR) obtained from ergometer test

OTHERresistance exercise

resistance exercise (RE): 4 series of 12 repetitions of resistance exercises at moderate intensity (until moderate fatigue), for 45 minutes

OTHERcombined exercise

combined exercise (CE): EA (25 minutes) + ER (20 minutes), with an interval of 2 minutes between sessions totalizing 45 minutes

Sponsors

Heitor Moreno Junior
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* the diagnosis recommended by the AHA Statement on Resistant Hypertension (2008) * a 6-month period clinic follow-up * give written informed consent form

Exclusion criteria

* secondary Hypertension * pseudoresistance hypertension (poor medication adherence and white coat hypertension) * patients with symptomatic ischemic heart disease, impaired renal function, liver disease and history of stroke, myocardial infarction and peripheral vascular diseases, heart failure * pregnant women * smoking * regular physical activity * mental or physical limitation

Design outcomes

Primary

MeasureTime frameDescription
systolic blood pressure in mmHg15 minutessystolic blood pressure will be assessed for 15 minutes in baseline, 60 minutes and 24 hours post each interventions.

Secondary

MeasureTime frameDescription
arterial stiffnessbaseline and 60 minutes post each interventionby pulse wave velocity, Sphygmocor CPV system
ambulatory blood pressure monitoringbaseline and post each interventionambulatory blood pressure will be assessed in baseline and post each intervention
interleukin 6baseline, 60 minutes and 24 hours post each interventioninterleukin 6 will be assessed by ELISA
interleukin 10baseline, 60 minutes and 24 hours post each interventioninterleukin 10 will be assessed by ELISA
tumor necrosis factor alphabaseline, 60 minutes and 24 hours post each interventiontumor necrosis factor alpha will be assessed by ELISA

Contacts

Primary ContactNayara F. Pires, PhD student
nayarafraccari@yahoo.com.br+551935219538

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026